Sipavibart Biosimilar - Research Grade

Human

Severe acute respiratory syndrome coronavirus 2

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Spike-protein binding underlies SARS-CoV-2 infection, keeping the antigen at the center of coronavirus neutralization research. This product is a research-grade, unconjugated analog of sipavibart, a recombinant monoclonal antibody against SARS-CoV-2, for research use only. Produced to in vivo standards with low endotoxin, it is available in scalable milligram to gram quantities to support bulk and high-throughput laboratories. It is suited to viral neutralization functional assays, in vitro receptor-binding-domain screens, and in vivo models of antiviral protection. Its purity and dependable supply support reproducible work in demanding, high-throughput settings. Consistent quality across lots makes it a practical choice for laboratories running sustained study programs.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks